SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14C - Other preliminary information statements:
SEC Accession No. 0001193125-18-361091
Filing Date
2018-12-28
Accepted
2018-12-28 17:21:18
Documents
1
Period of Report
2018-12-21

Document Format Files

Seq Description Document Type Size
1 PRE 14C d679573dpre14c.htm PRE 14C 243106
  Complete submission text file 0001193125-18-361091.txt   244281
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14C | Act: 34 | File No.: 001-13467 | Film No.: 181258085
SIC: 8731 Services-Commercial Physical & Biological Research